Related Experiment Video
Updated: Jan 20, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
The role of haemostasis in placenta-mediated complications
Jean-Christophe Gris1, Sylvie Bouvier2, Éva Cochery-Nouvellon3
1Department of Haematology, Nîmes University Hospital, France; University of Montpellier, France; The First I.M. Sechenov Moscow State Medical University, Russian Federation.
Abstract:
Normal pregnancy is associated with an increasing state of activation of the haemostatic system. This activation state is excessive in women with placenta-mediated pregnancy complications (PMPCs), including preeclampsia (PE). Platelet activation plays a crucial pathophysiological role in PE. The very early activation of coagulation in the intervillous space is mandatory for placental growth and morphogenesis but its excesses and/or inadequate control may participate to the emergence of the trophoblastic phenotype of PE. Extracellular vesicles, of endothelial but also of trophoblastic origin, can favour key cellular reactions of preeclampsia, acting as proactive cofactors. The understanding of this intricate relationship between haemostasis activation and PMPCs may provide interesting keys for new pathophysiological therapeutic developments.
Related Concept Videos
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
14:42Isolation and Analysis of Hematopoietic Stem Cells from the Placenta
06:54Ex Vivo Perfusion of the Rodent Placenta
05:31Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
07:37Isolation of Primary Human Decidual Cells from the Fetal Membranes of Term Placentae
Hemodialysis II: Procedure and Complications

